CTLA4 and cancer: Earlier reports suggested that PD-1 and CTLA-4 are associated with the suppressive functions of Treg cells (53, 54), but a consensus is emerging that these inhibitory receptors can individually restrict Treg capacity and suppressive function during autoimmune disease (20, 28), cancer (21, 41, 55) and infection (29).